CAPTRUST Financial Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,866
| Closed | -$96K | – | 4576 |
|
|
2022
Q2 | $96K | Buy |
3,866
+2,614
| +209% | +$64.9K | ﹤0.01% | 2227 |
|
|
2022
Q1 | $31K | Sell |
1,252
-2,652
| -68% | -$65.7K | ﹤0.01% | 3132 |
|
|
2021
Q4 | $142K | Buy |
3,904
+385
| +11% | +$14K | ﹤0.01% | 1900 |
|
|
2021
Q3 | $60K | Buy |
3,519
+175
| +5% | +$2.98K | ﹤0.01% | 2460 |
|
|
2021
Q2 | $45K | Buy |
3,344
+279
| +9% | +$3.75K | ﹤0.01% | 2584 |
|
|
2021
Q1 | $157K | Buy |
3,065
+15
| +0.5% | +$768 | ﹤0.01% | 1650 |
|
|
2020
Q4 | $189K | Buy |
3,050
+2,800
| +1,120% | +$174K | ﹤0.01% | 1209 |
|
|
2020
Q3 | $14K | Sell |
250
-2,800
| -92% | -$157K | ﹤0.01% | 2154 |
|
|
2020
Q2 | $177K | Sell |
3,050
-400
| -12% | -$23.2K | ﹤0.01% | 1091 |
|
|
2020
Q1 | $133K | Buy |
+3,450
| New | +$133K | ﹤0.01% | 1006 |
|
|
2019
Q4 | – | Sell |
-4,000
| Closed | -$27K | – | 1948 |
|
|
2019
Q3 | $27K | Buy |
4,000
+2,000
| +100% | +$13.5K | ﹤0.01% | 1216 |
|
|
2019
Q2 | $19K | Buy |
+2,000
| New | +$19K | ﹤0.01% | 1296 |
|